|
 |
 |
We
deliver your message to your target audience.
Our 200 million OPT-IN e-mails and 130 million
data files are targeted using cutting edge technology
with over 12 million specifically targeted to
the financial community. |
|
 |
|
|
Biomagnetics
Diagnostics Corporation
About Us
Biomagnetics
Diagnostics Corporation is an advanced medical
device and biotechnology company. Our revolutionary
diagnostics system and test kit testing
technology for HIV, Hepatitis, H-Pylori,
HPV, Tuberculosis and many other viruses,
bacterium's, toxins and diseases focuses
on real-time testing for the actual presence
of the virus/ toxin/ disease itself, and
not for antibodies produced by the body's
immune system which may take anywhere from
weeks to months to appear. This allows for
much earlier detection and treatment, as
well as delivering the test at a fraction
of current costs.
The
company is positioning itself to perform
clinical trials in Mexico, Thailand, India
and China in the first/second quarter
of 2009 followed by trials in the US and
Europe. Biomagnetics hopes to have products
in use in China by late 2009/ early 2010,
followed by US and European sales sometime
in 2011, pending successful financing
and approvals.
|
|
|
|
Business
Development/ Licensing/ Technology Partnerships
 Dr.
Hai Shiene Chen, President and CEO of ACGT
DNA Technologies Corporation, a leader in
Canada's DNA industry with extensive ties
to China. Dr. Chen and ACGT are currently
consulting on behalf of Biomagnetics in
regards to the use of various aspects of
the company's products and technology within
mainland China's healthcare and food industry.
They are also assisting Biomagnetics with
qualifying for the Chinese government's
incubator program to foster development
of a first class biotechnology industrial
complex on mainland China, an important
aspect of Biomagnetics' international development
strategy. |
|
|
|
|
| Clayton
M. Hardman - CEO |
| Exchange:
PINK |
| Shares
I/O:
40,448,399 |
| Symbol:
BMGP |
| 52
Week Range: $0.03 -
$.51 |
|
|
|
|
|
|
|
|
|
